This study is conducted to verify the relationships between yoga efficacy and bioactive materials in the blood of Korean elderly.
Full Title of Study: “The Studies of Yoga Efficacy and Bioactive Materials in the Blood of Korean Elderly”
- Study Type: Interventional
- Study Design
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Diagnostic
- Masking: None (Open Label)
- Study Primary Completion Date: January 31, 2021
Glycoproteomics approach will be applied to verify the relationships between yoga efficacy and bioactive materials in the blood of Korean elderly.
- Behavioral: Participation in the elderly yoga program
- Yoga participant groups will practice elderly yoga for four months.
Arms, Groups and Cohorts
- Experimental: Yoga participant groups
- Yoga participant groups will practice elderly yoga for four months. We will collect their blood before and after their participation in the elderly yoga program. There will be two subgroups which are Advanced group and Beginner group.
- No Intervention: Non-Yoga participant groups
- Non-Yoga participant groups will not practice yoga for four months and will be used as the control. We will collect their blood before and after the elderly yoga program. There will be two subgroups which are Elderly group and Young group.
Clinical Trial Outcome Measures
- Measuring the number of glycoproteins in blood between before and after participation in an elderly yoga program for both the Advanced group and Beginner group
- Time Frame: 4 months
- Glycoproteins in human plasma are known to be deeply associated with multiple diseases, cell differentiation, aging, and etc. The efficacy of elderly yoga will be assessed by identifying and comparing the number of glycoproteins in blood between before and after participation in an elderly yoga program for both the Advanced group and Beginner group.
Participating in This Clinical Trial
- The elderly group participant over 60 years old.
- The young group participant over 20 to 57 years old.
- Individual who can read and understand Korean.
- Participant is willing and able to give informed consent for participation in the study.
- Participant who was diagnosed with cancer in the last five years.
- In case of participants leaving the yoga program after the primary blood collecting, they will be excluded from the secondary blood collecting.
- Individuals who are judged inappropriate for the study.
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- Wonryeon Cho
- Provider of Information About this Clinical Study
- Sponsor-Investigator: Wonryeon Cho, Associate Professor – Wonkwang University
- Overall Official(s)
- Wonryeon Cho, PhD, Principal Investigator, Wonkwang University
- Overall Contact(s)
- Wonryeon Cho, PhD, 821066636224, firstname.lastname@example.org
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.